ZA946967B - Lyophillisate composition - Google Patents

Lyophillisate composition

Info

Publication number
ZA946967B
ZA946967B ZA946967A ZA946967A ZA946967B ZA 946967 B ZA946967 B ZA 946967B ZA 946967 A ZA946967 A ZA 946967A ZA 946967 A ZA946967 A ZA 946967A ZA 946967 B ZA946967 B ZA 946967B
Authority
ZA
South Africa
Prior art keywords
lyophillisate
composition
lyophillisate composition
Prior art date
Application number
ZA946967A
Inventor
Alan Duncan Robertson
Ross Andrew Shalliker
Jimmy Sosic
Original Assignee
Faulding F H & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faulding F H & Co Ltd filed Critical Faulding F H & Co Ltd
Publication of ZA946967B publication Critical patent/ZA946967B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
ZA946967A 1993-09-10 1994-09-09 Lyophillisate composition ZA946967B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM111393 1993-09-10

Publications (1)

Publication Number Publication Date
ZA946967B true ZA946967B (en) 1995-05-08

Family

ID=3777185

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946967A ZA946967B (en) 1993-09-10 1994-09-09 Lyophillisate composition

Country Status (2)

Country Link
WO (1) WO1995007083A1 (en)
ZA (1) ZA946967B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529057B4 (en) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamide lyophilizate preparations
DE19540132C2 (en) * 1995-10-27 2003-04-03 Stada Arzneimittel Ag Ifosfamide lyophilizate
AU1555099A (en) * 1997-10-13 1999-05-03 Stada Arzneimittel A.G. Liquid presentations of oxazaphosphorine-containing pharmaceutical products
CA2470472A1 (en) * 2001-12-13 2003-06-26 Sicor Inc. Aqueous ifosfamide composition
US6613927B1 (en) * 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO873860L (en) * 1986-10-31 1988-05-02 Asta Pharma Ag IFOSPHAMIDE LYOPHILIZATE AND PROCEDURE FOR THEIR PREPARATION.
ES2040394T3 (en) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft PROCEDURE FOR PREPARING A LYOPHILIZED MATERIAL OF IFOSFAMIDE AND MESNA.
US5036060A (en) * 1988-07-25 1991-07-30 Fujisawa Usa, Inc. Cyclophosphamide
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions

Also Published As

Publication number Publication date
WO1995007083A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
GB9318841D0 (en) Composition
AP9600798A0 (en) Novel composition
IL110665A0 (en) Erection-inducing compositions
ZA942052B (en) Tricritical point composition
GB9302130D0 (en) Cleasing composition
GB9318641D0 (en) Compositions
GB9313274D0 (en) Composition
GB9310700D0 (en) Novel composition
GB9323313D0 (en) Clenasing compositions
GB9404236D0 (en) Cable-making compositions
GB2281914B (en) Composition
PL311721A1 (en) Compositions
ZA946967B (en) Lyophillisate composition
ZA949377B (en) Novel composition
GB9301289D0 (en) Novel composition
GB2282385B (en) Composition
GB9313759D0 (en) Cementiferous compositions
GB9320370D0 (en) Frit-containing composition
GB9320598D0 (en) Composition
GB9321876D0 (en) Novel composition
GB9317257D0 (en) Composition
GB9317222D0 (en) Composition
GB9307790D0 (en) Composition
GB9314335D0 (en) Composition
GB9314513D0 (en) Composition